Although skin biopsies revealed post-treatment modulation of molecular markers including p-MAPK, p27 and Ki67, tumor biopsies merely demonstrated inhibition of MAPK phosphorylation with no impact on other biomarkers, such as p27 and Ki67 [38]. This evidence concerns the gene MKI67 and neoplasm.